Envista Reports 3rd Quarter 2022 Earnings.

BREA, Calif: Envista Holdings Corporation (NYSE: NVST) today announced results for the third quarter 2022.

As previously disclosed, on December 31, 2021, we completed the sale of the KaVo Treatment Unit and Instrument business. All results in this release reflect only continuing operations unless otherwise noted.

For the quarter ended September 30, 2022, reported sales increased 3.9% to $631.1 million with core sales growth of 4.9% over the corresponding quarter in 2021.

For the third quarter of 2022, net income was $49.6 million or $0.28 per diluted share. During the same period, adjusted net income was $82.5 million or $0.47 per diluted share compared to adjusted net income of $79.4 million or $0.45 per diluted share in the same period of 2021. Adjusted EBITDA for the third quarter of 2022 was $127.6 million compared to $119.1 million in the third quarter of 2021.

Amir Aghdaei, Chief Executive Officer, stated, "We are pleased that despite a challenging macro environment, the Envista team has once again delivered a strong quarter with core sales growth of 4.9% and an adjusted EBITDA margin of 20.2%. Our consistent performance, driven by the Envista Business System (EBS), is a testament to the strength of our team, culture, and strategic differentiation. We have a proven track record of execution and remain committed to our long-term objectives."

Mr. Aghdaei continued, "In addition to delivering solid results in the third quarter, the...